Back to News
Market Impact: 0.2
CAPR 5-DAY DEADLINE: Capricor Investors Have Opportunity to Lead Class Action
Source: businesswire.com
Legal & LitigationHealthcare & Biotech
Hagens Berman is investigating claims tied to a class-action complaint filed on behalf of investors against Capricor Therapeutics. The notice signals potential securities-litigation risk for CAPR, though no allegations, damages, or case-specific financial impact were provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
CAPR-0.80
More News
- OpenAI’s agent hacked Australia’s Medicare website—the latest rogue AI incident that the company didn’t know about for months
- How Meta took the lead in the race for the post-smartphone world
- Australia says OpenAI agent hacked Medicare portal
- US aviation sanctions disrupt Iran flights, push travellers overland
- Meta Debuts $349 Camera-Free Ray-Bans and Brings Muse to Glasses
- OpenAI agents ‘infiltrated Australian government website’